Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
24,274,421
-
Shares change
-
-2,353,527
-
Total reported value, excl. options
-
$1,679,824,791
-
Value change
-
-$160,429,955
-
Put/Call ratio
-
203%
-
Number of buys
-
103
-
Number of sells
-
46
-
Price
-
$69.23
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q3 2020
As of 30 Sep 2020 BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) had 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,274,421 shares of stock of the company.
Largest 10 holders included FMR LLC, PRIMECAP MANAGEMENT CO/CA/, Artisan Partners Limited Partnership, Artal Group S.A., Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, AMERIPRISE FINANCIAL INC, Invesco Ltd., and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 144 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.